LONDON: The UK Government has authorised the use of anti-inflammatory drug dexamethasone for the treatment of Covid-19 on the National Health Service (NHS), immediately after the report of positive data from the RECOVERY trial.

Preliminary data showed that the low-cost, commonly available drug reduced death by up to one third in hospitalised patients with severe respiratory complications caused by Covid-19.

The drug has been approved for the treatment of patients needing oxygen, including those on ventilators.

According to the trial results, dexamethasone decreased the risk of death by 35% in patients on ventilation and 20% in patients on oxygen, leading to a 17% reduction in the total 28-day mortality rate.

Originally Posted on Abbtak Tv


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.